Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Irradia is a Swedish medical technology company focused on laser medicine and low-level laser therapy (LLLT). The company develops, manufactures, and supports non-invasive therapeutic laser devices used to reduce pain and inflammation and to promote healing. Its product portfolio includes professional and home-care laser systems such as MidCare, Mid-Laser, and Mid-Lite, and it also supports animal-care applications. In addition to selling devices, Irradia provides training, courses, and service support for clinicians and customers. The company appears to operate as a commercial-stage medtech business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Irradia.